ADC for differentiation between posttreatment changes and recurrence in head and neck cancer: a systematic review and meta-analysis

A Baba, R Kurokawa, M Kurokawa… - American Journal …, 2022 - Am Soc Neuroradiology
BACKGROUND: Previous studies reported that the ADC values of recurrent head and neck
cancer lesions are lower than those of posttreatment changes, however, the utility of ADC to …

Differentiation of recurrent tumor and posttreatment changes in head and neck squamous cell carcinoma: application of high b-value diffusion-weighted imaging

I Hwang, SH Choi, YJ Kim, KG Kim… - American Journal …, 2013 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: High b-value DWI has been expected to have an
additional diagnostic role and demonstrated some promising results in head and neck …

[HTML][HTML] Pretreatment ADC is not a prognostic factor for local recurrences in head and neck squamous cell carcinoma when clinical T-stage is known

B Peltenburg, JP Driessen, JE Vasmel, FA Pameijer… - European …, 2020 - Springer
Objectives Pretreatment identification of radio-insensitive head and neck squamous cell
carcinomas (HNSCC) would affect treatment modality selection. The apparent diffusion …

Differentiating recurrent tumours from post-treatment changes in head and neck cancers: does diffusion-weighted MRI solve the eternal dilemma?

S Vaid, A Chandorkar, A Atre, D Shah, N Vaid - Clinical Radiology, 2017 - Elsevier
Aim To evaluate the utility of diffusion-weighted imaging (DWI) in differentiating post-
treatment changes from tumour recurrence in head and neck cancers and to establish a …

Fractional change in apparent diffusion coefficient as an imaging biomarker for predicting treatment response in head and neck cancer treated with …

M Matoba, H Tuji, Y Shimode… - American Journal …, 2014 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: ADC provides a measure of water molecule diffusion in
tissue. The aim of this study was to evaluate whether the fractional change in ADC during …

[HTML][HTML] Predictive value of early post-treatment diffusion-weighted MRI for recurrence or tumor progression of head and neck squamous cell carcinoma treated with …

E Brenet, C Barbe, C Hoeffel, X Dubernard, JC Merol… - Cancers, 2020 - mdpi.com
Aims: To investigate the predictive capacity of early post-treatment diffusion-weighted
magnetic resonance imaging (MRI) for recurrence or tumor progression in patients with no …

Differentiation of benign and malignant pathology in the head and neck using 3T apparent diffusion coefficient values: early experience

A Srinivasan, R Dvorak, K Perni… - American journal …, 2008 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: The purpose of this work was to study differences in
apparent diffusion coefficient (ADC) values between benign and malignant head and neck …

Apparent diffusion coefficient calculated with relatively high b-values correlates with local failure of head and neck squamous cell carcinoma treated with radiotherapy

M Hatakenaka, Y Shioyama… - American journal …, 2011 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Few studies have investigated the relationship between
ADC and clinical outcome in HNSCC. Our hypothesis has that relatively high pretreatment …

Head and neck squamous cell carcinoma: diagnostic performance of diffusion-weighted MR imaging for the prediction of treatment response

AD King, KK Chow, KH Yu, FKF Mo, DKW Yeung… - Radiology, 2013 - pubs.rsna.org
Purpose To determine the diagnostic performance of diffusion-weighted (DW) imaging for
the prediction of treatment failure in primary head and neck squamous cell carcinoma …

Apparent diffusion coefficient agreement and reliability using different region of interest methods for the evaluation of head and neck cancer post chemo-radiotherapy

M Anjari, A Guha, C Burd, M Varela… - Dentomaxillofacial …, 2021 - academic.oup.com
Objectives: Post chemoradiotherapy (CRT) interval changes in apparent diffusion coefficient
(ADC) have prognostic value in head and neck squamous cell cancer (HNSCC). The impact …